Trial Outcomes & Findings for Home or Away From Home - Descriptive Interviews (Aim 2) (NCT NCT02794207)
NCT ID: NCT02794207
Last Updated: 2020-01-27
Results Overview
Issues related to type of neutropenia management are not quantifiable. All interviewees gave unique responses to issues related to neutropenia management, and themes were identified after all interviews were conducted and analyzed.
COMPLETED
86 participants
One qualitative semi-structured interview was conducted post-neutropenia management. The interview lasted about 30-45 minutes.
2020-01-27
Participant Flow
Participant milestones
| Measure |
Participants
One qualitative, semi-structured interview will be conducted. Each interview will last approximately 30-45 minutes and may be audio recorded (if consent is provided). Interviews will consist of several open-ended questions focusing on having the participant reflect upon past experiences with neutropenia management and the impact of the participant's illness and treatment. Several close-ended questions regarding participant's thoughts on potential outcomes will also be included.
|
Caregivers
One qualitative, semi-structured interview will be conducted. Each interview will last approximately 30-45 minutes and may be audio recorded (if consent is provided). Interviews will consist of several open-ended questions focusing on having the participant reflect upon past experiences with neutropenia management and the impact of their child's illness and treatment. Several close-ended questions regarding participant's thoughts on their child's potential outcomes will also be included.
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
54
|
|
Overall Study
COMPLETED
|
32
|
54
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Home or Away From Home - Descriptive Interviews (Aim 2)
Baseline characteristics by cohort
| Measure |
Patients
n=32 Participants
Patients who participated in a qualitative interview about their experience with AML. One qualitative, semi-structured interview was conducted. Each interview lasted approximately 30-45 minutes and may be audio recorded (if consent is provided).
|
Caregivers
Caregivers who participated in a qualitative interview about their experience with AML. One qualitative, semi-structured interview was conducted. Each interview lasted approximately 30-45 minutes and may be audio recorded (if consent is provided).
|
Total
n=32 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
23 Participants
n=5 Participants
|
—
|
23 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
—
|
9 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
—
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
14.4 years
STANDARD_DEVIATION 6.54 • n=5 Participants
|
—
|
14.4 years
STANDARD_DEVIATION 6.54 • n=5 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=5 Participants
|
—
|
17 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
15 Participants
n=5 Participants
|
—
|
15 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
32 participants
n=5 Participants
|
—
|
32 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: One qualitative semi-structured interview was conducted post-neutropenia management. The interview lasted about 30-45 minutes.Population: All participants (patients and caregivers) who participated in the semi-structured interviews. 3 key, novel themes were identified across these interviews.
Issues related to type of neutropenia management are not quantifiable. All interviewees gave unique responses to issues related to neutropenia management, and themes were identified after all interviews were conducted and analyzed.
Outcome measures
| Measure |
Participants
n=86 Participants
One qualitative, semi-structured interview will be conducted. Each interview lasted approximately 30-45 minutes and were audio recorded (if consent is provided). Interviews consisted of several open-ended questions focusing on having the participant reflect upon past experiences with neutropenia management and the impact of the participant's illness and treatment. Several close-ended questions regarding participant's thoughts on potential outcomes were also included.
|
|---|---|
|
Issues Related to Type of Neutropenia Management That Are Most Important to Children and Their Caregivers.
|
3 key themes identified
|
Adverse Events
Participants
Caregivers
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place